[ANXA1 might be a biomarker candidate for breast cancer survival prediction in high risk groups such as HER2+ cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE